Immunization To Prevent Acute COPD Exacerbations (IMPACE Study)

Trial Profile

Immunization To Prevent Acute COPD Exacerbations (IMPACE Study)

Phase of Trial: Phase IV

Latest Information Update: 06 Jun 2018

At a glance

  • Drugs Pneumococcal 13-valent CRM197 vaccine conjugate (Primary)
  • Indications Pneumococcal infections
  • Focus Therapeutic Use
  • Acronyms IMPACE Study
  • Sponsors Pfizer
  • Most Recent Events

    • 14 Dec 2017 Status changed from not yet recruiting to recruiting.
    • 11 Oct 2017 Planned initiation date changed from 29 Sep 2017 to 27 Oct 2017.
    • 11 Sep 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top